Aug 12, 2020
Milestone Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Clinical and Corporate Update
May 14, 2020
Milestone Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Clinical and Corporate Update
May 08, 2020
Biosense Webster Unveils Late-Breaking Results from PRECEPT Study in Patients with Persistent Atrial Fibrillation
Mar 23, 2020
Milestone Pharmaceuticals Announces Topline Results from First-of-its-kind Phase 3 NODE-301 Trial of Etripamil for At-home Acute PSVT Treatment
Mar 06, 2020
Milestone Pharmaceuticals Reports Fourth Quarter and Year-end 2019 Financial Results and Provides Clinical and Corporate Update
Oct 03, 2019
Milestone Pharmaceuticals Announces First Patient Enrolled in NODE-303 Open-label Safety Study of Etripamil in PSVT
May 09, 2019
Varian Acquires CyberHeart
May 07, 2019
Vytronus Reaches Enrollment Milestone in Clinical Trial of Automated Ultrasound Technology for Treatment of Persistent Atrial Fibrillation
May 07, 2019
HRS 2019: Acutus Medical to Demonstrate Major Advances in Electrophysiology Field
Apr 23, 2019
FDA Grants First-Ever Clearances to Detect Bradycardia and Tachycardia on a Personal ECG Device
Oct 29, 2018
Correvio Announces Brinavess Eligibility for Patent Extension
Oct 24, 2018
Cipher Pharmaceuticals Announces Canadian Launch of Brinavess® (vernakalant hydrochloride)
Oct 23, 2018
Correvio Announces Intention to Re-File Brinavess® NDA in Second Quarter 2019
Aug 14, 2018
Correvio Announces Brinavess® Selected as Potentially Eligible for Priority Review in China
Aug 08, 2018
Milestone Pharmaceuticals Announces First Patient Randomized in the Phase 3 NODE-301 Clinical Trial Evaluating Etripamil for Termination of Paroxysmal Supraventricular Tachycardia (PSVT) Episodes
Jun 18, 2018
Milestone Pharmaceuticals Announces Launch of OutsmartPSVT.com Supporting Patients with PSVT, a Common and Underdiagnosed Heart Disorder
Jun 11, 2018
Correvio Provides U.S. Regulatory Update for BRINAVESS
May 17, 2018
Correvio Announces Enrollment of First Patient in Phase 3 Study Evaluating Brinavess® in China
May 07, 2018
Affera's Novel Technology For Cardiac Arrhythmia Treatment To Be Featured In 8 Scientific Sessions At The 2018 Heart Rhythm Society Meeting
Apr 17, 2018
Cardiome Completes Enrollment in the Post Approval Safety Study SPECTRUM Evaluating Brinavess®